Astrazeneca (AZN) Earnings (2006 - 2026)
Astrazeneca (AZN) earnings from Mar 31, 2006 to Mar 31, 2026. The TTM Astrazeneca (AZN) earnings is $10B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Astrazeneca (AZN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +33.67% |
| 3 Years TTM | +30.23% |
| 5 Years TTM | +21.17% |
| 10 Years TTM | +13.53% |
| All Time TTM | +2.77% |
Annual Earnings change of Astrazeneca (AZN)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $3.08B | -69.97% |
| 2025 | $10B | +45.77% |
| 2024 | $7.04B | +18.14% |
| 2023 | $5.96B | +81.11% |
| 2022 | $3.29B | +2835.71% |
| 2021 | $112M | -96.50% |
| 2020 | $3.20B | +139.40% |
| 2019 | $1.33B | -38.05% |
| 2018 | $2.15B | -28.19% |
| 2017 | $3B | -14.23% |
| 2016 | $3.50B | +23.86% |
| 2015 | $2.83B | +129.12% |
| 2014 | $1.23B | -51.76% |
| 2013 | $2.56B | -59.04% |
| 2012 | $6.24B | -37.08% |
| 2011 | $9.92B | +23.15% |
| 2010 | $8.05B | +7.07% |
| 2009 | $7.52B | +23.27% |
| 2008 | $6.10B | +9.04% |
| 2007 | $5.59B | -7.41% |
| 2006 | $6.04B | N/A |
Comparison Astrazeneca (AZN) five years earnings CAGR with competitors
Astrazeneca (AZN) five years earnings CAGR is 21.17%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 98.24% | +364.01% |
| LLY | Lilly(Eli) & Company | 32.92% | +55.48% |
| NVO | Novo Nordisk | 23.10% | +9.13% |
| NVS | Novartis AG | 11.21% | -47.04% |
| JNJ | Johnson & Johnson | 6.84% | -67.70% |
| MRK | Merck & Co Inc | 4.92% | -76.75% |
| GSK | GSK Plc | 2.84% | -86.57% |
| AMGN | AMGEN Inc | 1.94% | -90.83% |